About this trial
This is an observational study in newborn term and preterm infants. The study will validate if non-invasive continuous cardiac output monitoring is feasible in newborn infants, if normative values can be constructed and what is the effect of fluid boluses and inotropes on cardiac output and peripheral vascular resistance.
Eligibility criteria
Qualifiers
Healthy term infants in postnatal ward (within the first 72 hours of age)
Term and Preterm infants (including those with FGR) admitted to the neonatal unit
Written informed parental consent (prospective for postnatal ward and retrospective for babies admitted to the neonatal units)
Disqualifiers
Antenatal or postnatal diagnosis of severe congenital anomaly
Infants with no realistic chance of survival
Infants who are >12 hours of age
Infants with fragile skin not permitting skin probe placement
Trial design
Treatments tested in this trial
- NICAS cardiac output monitor